ReposiTrak (TRAK) Cash & Equivalents (2010 - 2025)

ReposiTrak has reported Cash & Equivalents for 16 years, with the latest figure at $28.7 million in Q4 2025.

• On a quarterly basis, Cash & Equivalents rose 2.37% year-over-year to $28.7 million in Q4 2025; TTM through Dec 2025 was $28.7 million, a 2.37% increase from a year earlier, with the FY2025 full-year figure at $28.6 million, up 13.58% from the prior year.
• Cash & Equivalents was $28.7 million for Q4 2025 at ReposiTrak, roughly flat from $28.8 million in the prior quarter.
• The five-year high for Cash & Equivalents was $28.8 million in Q3 2025, with the low at $20.4 million in Q3 2021.
• Average Cash & Equivalents over 5 years is $24.3 million, with a median of $23.8 million recorded in 2023.
• The sharpest annual moves came in 2021 and 2022: Cash & Equivalents rose 29.59% in 2021, then slipped 10.84% in 2022.
• Over 5 years, Cash & Equivalents stood at $21.7 million in 2021, then dropped by 1.42% to $21.4 million in 2022, then rose by 8.66% to $23.3 million in 2023, then grew by 20.59% to $28.0 million in 2024, then climbed by 2.37% to $28.7 million in 2025.
• The last three Cash & Equivalents figures came in at $28.7 million (Q4 2025), $28.8 million (Q3 2025), and $28.6 million (Q2 2025), per Business Quant data.